We are live on
!
Find out more
3C
325 Capital Portfolio holdings
AUM
$419M
1-Year Est. Return
75.74%
This Fund
S&P 500
This Quarter
Est. Return
-12.23%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$30.5M
(-20%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
2
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astrana Health
ASTH
|
+$3.56M |
| 2 |
DSKE
Daseke, Inc. Common Stock
DSKE
|
+$3.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
|
+$18.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 42.97% |
| 2 | Healthcare | 31% |
| 3 | Consumer Discretionary | 15.4% |
| 4 | Technology | 5.36% |
| 5 | Consumer Staples | 5.27% |
Similar funds
PWA
BA
UOC
RBFC
LSWP
XWM
NTCM
DAS
325 Capital's Q3 2023 Portfolio in Review
As of Q3 2023, 325 Capital held 9 positions worth $121M, down 20% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
325 Capital withdrew a net $11.5M in Q3 2023, closing 1 position. Its most notable exit was NextGen Healthcare, Inc. Common Stock, an estimated $18.6M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, 325 Capital added an estimated $3.56M to Astrana Health.
- 325 Capital added most to Astrana Health in Q3 2023, an estimated $3.56M increase.
- 325 Capital fully exited NextGen Healthcare, Inc. Common Stock in Q3 2023, selling an estimated $18.6M.
- 325 Capital's ten largest holdings make up 100% of its $121M portfolio in Q3 2023.
- 325 Capital opened 0 new positions and closed 1 in Q3 2023.
- 325 Capital's portfolio value fell 20% quarter-over-quarter to $121M.
Based on 325 Capital's 13F filing for Q3 2023, filed 14 Nov 2023.